DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy

Abstract

Measurements of RIF and the absorbed dose to the blood after systemic administration of (177)Lu may be used to obtain data on the individual dose-response relationships in vivo. Individual patient data were characterized by a linear dose-dependent increase and an exponential decay function describing repair.